Suchowierska Ewa, Myśliwiec Michał
Uniwersytet Medyczny w Białymstoku, Klinika Nefrologii i Transplantologii.
Pol Merkur Lekarski. 2010 Feb;28(164):138-43.
In the course of chronic kidney disease (CKD) comes to the disturbances in mineral and bone metabolism and extra-skeletal calcification. In subsequent stages of CKD, these processes intensify, leading to a deterioration in the quality of life and disability. They are also a major cause of morbidity and mortality from cardiovascular causes in CKD. In 2005, the Organization of Kidney Disease: Improving Global Outcomes (KIDGO), proposed replacing the term Renal Osteodystrophy in mineral and bone complications CKD (chronic kidney disease mineral and bone related disorders; CKD-MBD) as the disorder is not confined to the skeleton. CKD-MBD is manifested by the presence of changes in laboratory tests (corrected serum calcium, organic phosphate, parathyroid hormone, concentrations of vitamin D derivatives), changes in bone (bone metabolism, bone mineralization and trabecular bone volume), the occurrence of calcifications in the soft tissues and the arterial vessels.
在慢性肾脏病(CKD)病程中会出现矿物质和骨代谢紊乱以及骨骼外钙化。在CKD的后续阶段,这些过程会加剧,导致生活质量下降和残疾。它们也是CKD患者心血管疾病发病和死亡的主要原因。2005年,改善全球肾脏病预后组织(KIDGO)提议用慢性肾脏病矿物质和骨异常(CKD-MBD)取代CKD矿物质和骨并发症中的肾性骨营养不良这一术语,因为该病症并不局限于骨骼。CKD-MBD表现为实验室检查结果的变化(校正血清钙、有机磷、甲状旁腺激素、维生素D衍生物浓度)、骨骼变化(骨代谢、骨矿化和骨小梁体积)、软组织和动脉血管中钙化的发生。